Palisade Bio, Inc.
PALI· Nasdaq
PALIPalisade Bio, Inc.
Released Aug 10, 2026, after the close
10-Q filed Aug 10, 2026, 41 days after period end · 0001357459-26-000016
| Metric | Q2 2026 | Q2 2025 | Q2 2024 | Q2 2023 |
|---|---|---|---|---|
| Revenue | $500.00K | $0.00 | $0.00 | $0.00 |
| Net Income | -$10.57M | -$2.78M | -$4.08M | -$3.39M |
| EPS Diluted |
Palisade Bio, Inc. · CIK 1357459 · Engraved from SEC EDGAR
| -$0.05 |
| -$0.58 |
| -$3.32 |
| -$7.93 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
